Article Text

SAT0486 Reference Intervals for Bone Turnover Markers in Spanish Premenopausal Women
  1. N. Guañabens1,
  2. X. Filella1,
  3. A. Monegal1,
  4. C. Gomez-Vaquero2,
  5. M. Bonet3,
  6. D. Buquet4,
  7. E. Casado5,
  8. D. Cerda6,
  9. A. Erra7,
  10. S. Martinez8,
  11. N. Montala9,
  12. C. Pitarch10,
  13. E. Kanterewicz11,
  14. M. Sala12,
  15. X. Suris13,
  16. F. Torres14
  17. on behalf of LabOscat Study Group. Societat Catalana de Reumatologia
  1. 1Hospital Clinic, Barcelona
  2. 2Hospital Universitari Bellvitge, L'Hospitalet
  3. 3Hospital de l'Alt Penedes, Villafranca
  4. 4Hospital Arnau de Vilanova, Lleida
  5. 5Hospital Parc Tauli, Sabadell
  6. 6Hospital Moises Broggi
  7. 7Hospital Sant Rafael, Barcelona
  8. 8Hospital Mutua Terrassa, Terrassa
  9. 9Hospital Santa Maria, Lleida
  10. 10Hospital Esperit Sant, Santa Coloma de Gramanet
  11. 11Hospital de Vic, Vic
  12. 12Hospital de Figueras, Figueras
  13. 13Hospital de Granollers, Granollers
  14. 14Universitat Autonoma, Barcelona, Spain


Background Bone turnover markers (BTMs) are used in clinical practice for assessing patients with osteoporosis and their treatment. In Spain it is necessary to fine-tune the reference intervals, since they were established years ago in a low number of individuals.

Objectives The aims of this study were to establish robust reference intervals for BTMs in healthy young premenopausal Spanish women and to investigate the factors influencing BTMs.

Methods 185 women aged 35 to 45 yrs. from 13 centres in Catalonia were recruited. Blood and second void urine samples were collected between 8 and 10 a.m. after an overnight fast. Serum PINP and βCTX were measured by two automated methods (Elecsys, Rochea and IDS-ISYS, Immunodiagnostic Systemsb), bone ALP by ELISA (IDS, Vitro), osteocalcin by IRMA (Cis Bio) and urinary NTX by ELISA (Osteomark, Vitro). PTH and 25OHD levels were measured in all participants, who completed a questionnaire on lifestyle factors. A quantile regression was fit to estimate the 5%, 50% and 95% percentiles for the BMTs, and the Fisher's exact test and non-parametric tests were used to assess the influence of factors on BTMs.

Results The median (P5-P95) for BTMs were: Bone ALP 9.3 (6.0-13.8) ng/ml, PINPa 35.9 (20.8-60.6) ng/ml, PINPb 35.8 (20.8-64.9) ng/ml, NTX 32.7 (19.3-68.9) nM/mM, CTXa 0.250 (0.137-0.480) ng/ml, CTXb 0.246 (0.107-0.541), Osteocalcin 14.0 (8.0-23.0) ng/ml.

Oral contraceptive pills (OCPs) were reported in 10.9% of participants, mean BMI was 23 and 60% had 25OHD levels lower than 20 ng/ml. Women on OCPs had lower PINP levels (p=0.007).25OHD levels didn't influence BTMs, but low BMI was associated with higher levels of almost all BTMs.

Conclusions In conclusion, robust reference intervals for BTMs in a southern European country are provided.

Acknowledgements This study was funded by a research grant from de Societat Catalana de Reumatologia.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.1755

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.